SCHEMBL21722571

SCHEMBL21722571

COc1ccc(CNc2cccc(C)c2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.65
NPC1 O15118 5/20 0.65
RAB9A P51151 5/20 0.65
L3MBTL1 Q9Y468 2/20 0.65
LMNA P02545 2/20 0.65
ALDH1A1 P00352 5/20 0.64
GAA P10253 3/20 0.58
NPSR1 Q6W5P4 1/20 0.58
PPARA Q07869 1/20 0.55
MEN1 O00255 1/20 0.55
KMT2A Q03164 1/20 0.55
HIF1A Q16665 1/20 0.54
POLB P06746 1/20 0.53
CYP1A2 P05177 1/20 0.53
CYP3A4 P08684 1/20 0.53
CYP2D6 P10635 1/20 0.53
CYP2C9 P11712 1/20 0.53
CYP2C19 P33261 1/20 0.53
HTT P42858 1/20 0.53
KDM4E B2RXH2 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14689659 0.87 MAPT (0.64) MAPTNPC1RAB9AL3MBTL1LMNA
SCHEMBL30480895 0.87 MAPT (0.64) MAPTNPC1RAB9AL3MBTL1LMNA
SCHEMBL27734845 0.85 MAPT (0.66) MAPTNPC1RAB9AL3MBTL1LMNA
SCHEMBL10055018 0.83 NOS1 (0.63) MAPTNPC1RAB9AL3MBTL1LMNA
SCHEMBL10267340 0.83 MAPT (0.68) MAPTNPC1RAB9AL3MBTL1LMNA
SCHEMBL701987 0.83 NLRP3 (0.62) MAPTNPC1RAB9AL3MBTL1LMNA
SCHEMBL16966286 0.83 MAPT (0.59) MAPTNPC1RAB9AL3MBTL1LMNA
SCHEMBL14808999 0.83 MAPT (0.67) MAPTNPC1RAB9AL3MBTL1LMNA
SCHEMBL17602062 0.83 NPC1 (0.65) MAPTNPC1RAB9AL3MBTL1LMNA
SCHEMBL2079779 0.83 MAPT (0.64) MAPTNPC1RAB9AL3MBTL1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024083168-A1 OXAZEPINE COMPOUNDS COMPRISING A 6-AZA MOIETY AND USES THEREOF GENENTECH, INC. (US) 2024-04-25 WO disclosed
CN-117736226-A pan-KRAS inhibitors and their use in medicine 贝达药业股份有限公司 2024-03-22 CN disclosed
CN-112119075-B Condensed ring compound 豪夫迈·罗氏有限公司 2024-03-12 CN disclosed
CN-117586280-A KRAS G12D inhibitor and application thereof in medicine 贝达药业股份有限公司 2024-02-23 CN disclosed
CN-117083279-A Oxazepine compounds and their use in the treatment of cancer 基因泰克公司 2023-11-17 CN disclosed
CN-112119075-A Fused ring compound 豪夫迈·罗氏有限公司 2020-12-22 CN disclosed
EP-3746436-A1 FUSED RING COMPOUNDS F. Hoffmann-La Roche AG (CH) 2020-12-09 EP disclosed
WO-2020035031-A1 FUSED RING COMPOUNDS GENENTECH, INC. (US) 2020-02-20 WO disclosed